Androgen Receptor Roles in Benign and Malignant Prostate Disease
Androgen deprivation therapy (ADT), which aims to reduce androgen–androgen receptor (AR) signaling, is the normal method of prostate cancer treatment. Despite its early success in suppressing prostate tumor growth, the therapy eventually fails, leading to recurrent hormone-refractory tumor growth. R...
I tiakina i:
| Hōputu: | Artigo |
|---|---|
| Reo: | Inglês |
| I whakaputaina: |
China Anti-Cancer Association
2011-06-01
|
| Rangatū: | Cancer Biology & Medicine |
| Ngā marau: | |
| Urunga tuihono: | http://www.cancerbiomed.org/index.php/cocr/article/view/49 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|